Ad
related to: big pharma's
Search results
Little Green Pharma Ltd's (ASX:LGP) Profit Outlook
Simply Wall St. via Yahoo Finance· 3 hours agoWe've put together a brief outline... Pharmaceuticals analysts is that Little Green Pharma is on the verge of breakeven. They anticipate the company to...
There's a way to see what Big Pharma is paying your doctor
Quartz· 5 days agoWhen doctors take money or gifts from pharmaceutical companies those are required by law to be...
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
InvestorPlace· 1 day agoMany investors expected today’s move in GlaxoSmithKline (NYSE:GSK), with shares of GSK stock...
Biden’s shortsighted patent attacks threaten American innovation
The Hill· 13 hours agoThe Biden administration is quietly advancing a proposal that could devastate America’s high-tech...
Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'
Rolling Stone· 1 day agoNever one to miss an opportunity to perform for C-SPAN’s cameras, Rep. Marjorie Taylor Greene...
Pharma’s $1 Trillion ‘Firepower’ Hangs Over Biotech Stocks in Limbo
Bloomberg· 1 day agoA flurry of deals at the start of the year sparked optimism for a biotech stock resurgence but a...
Tuesday's letters: Problem with weight-loss drugs is their fat price
Greensboro News & Record· 13 hours agoWhile I do agree with the title, “Insurance coverage for obesity can allow more to benefit,” I don’t...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
INSIDER via Yahoo News· 3 days agoThe FDA approved the pharma giant's new weight-loss drug in November. The market for weight-loss...
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
Investor's Business Daily· 3 hours agoA Takeover Candidate? William Blair's Hsieh says the data could bolster investors' expectations that...
Private Equity Puts Brakes on Healthcare Roll-Ups After Government Scrutiny
The Wall Street Journal· 14 hours agoBritton Costa, head of healthcare and pharma at credit-analysis company Fitch Ratings, says the...